ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The company is dedicated to using its unique patented know-how to develop innovation in cancer care through genuine research and clinical trials.
Following extensive research and development, ChemoTech recently launched the IQwave™ – the next generation of electroporation devices with gentle yet effective and flexible treatment capabilities. The IQwave™ has been developed to achieve positive clinical outcomes on a level previously not possible. The IQwave™ is intended to be used in performing Electrochemotherapy, a treatment approved for the treatment of a wide range of tumours. Read more»
The next step for ChemoTech is to expand its product portfolio into effective pain management for cancer patients.
ChemoTech has established distribution channels and a network of key opinion leaders in South East ASIA, India and Philippines.